Cargando…

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in young children and a substantial contributor to respiratory tract disease throughout life and as such a high priority for vaccine development. However, after nearly 60 years of research no vaccine is ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyoglu-Barnum, Seyhan, Chirkova, Tatiana, Anderson, Larry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677153/ https://www.ncbi.nlm.nih.gov/pubmed/31402910 http://dx.doi.org/10.3389/fimmu.2019.01675

Ejemplares similares

Effect of Infant RSV Infection on Memory T Cell Responses at Age 2-3 Years
por: Chirkova, Tatiana, et al.
Publicado: (2022)

In vitro model for the assessment of human immune responses to subunit RSV vaccines
por: Chirkova, Tatiana, et al.
Publicado: (2020)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2023)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

TLR7 promotes chronic airway disease in RSV-infected mice
por: Miles, Mark A., et al.
Publicado: (2023)

Immunity to RSV in Early-Life
por: Lambert, Laura, et al.
Publicado: (2014)

RSV Infection in Neonatal Mice Induces Pulmonary Eosinophilia Responsible for Asthmatic Reaction
por: Zhang, Dan, et al.
Publicado: (2022)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019)

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
por: Bergeron, Harrison C., et al.
Publicado: (2023)

The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis
por: Sebina, Ismail, et al.
Publicado: (2020)

ITGB4 Deficiency in Airway Epithelium Aggravates RSV Infection and Increases HDM Sensitivity
por: Du, Xizi, et al.
Publicado: (2022)

Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
por: Maier, Clara, et al.
Publicado: (2022)

MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice
por: Paulsen, Michelle, et al.
Publicado: (2020)

Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study
por: Pischedda, Sara, et al.
Publicado: (2022)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
por: Esposito, Susanna, et al.
Publicado: (2022)

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
por: Krause, Anja, et al.
Publicado: (2011)

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves
por: de Jong, Rineke, et al.
Publicado: (2022)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)

Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection
por: Bindernagel, Constance, et al.
Publicado: (2023)

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
por: D’Sa, Sucheta, et al.
Publicado: (2022)

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
por: Stahel, Philip F., et al.
Publicado: (2020)

Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation
por: Eichinger, Katherine M., et al.
Publicado: (2022)

mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection
por: Cheon, In Su, et al.
Publicado: (2019)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?
por: Naqvi, Afsar R., et al.
Publicado: (2018)

Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19
por: Yong, Yean Kong, et al.
Publicado: (2022)

A DNA Vaccine in Which the RSV-F Ectodomain Is Covalently Linked to the Burkholderia pseudomallei Antigens TssM and Hcp1 Augments the Humoral and Cytotoxic Response in Mice
por: Solodushko, Victor, et al.
Publicado: (2019)

Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
por: Bian, Lijun, et al.
Publicado: (2022)

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams
por: Kosanovich, Jessica L., et al.
Publicado: (2023)

Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination
por: Chirkova, Tatiana, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hacim2stdb8ecbqmkt8f21v3jd